The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Antimicrobial Agents and Chemotherapy
Open accessAbstract
Among emerging non-albicans Candida species, Candida parapsilosis is of particular concern as a cause of nosocomial bloodstream infections in neonatal and intensive care unit patients.While fluconazole and echinocandins are considered effective treatments for such infections, recent reports of fluconazole and echinocandin resistance in C. parapsilosis indicate a growing problem.The present study describes a novel mechanism of antifungal resistance in this organism affecting susceptibility to azole and echinocandin antifungals in a clinical isolate obtained from a patient with prosthetic valve endocarditis.Transcriptome analysis indicated differential expression of several genes in the resistant isolate, including upregulation of ergosterol biosynthesis pathway genes ERG2, ERG5, ERG6, ERG11, ERG24, ERG25, and UPC2.Whole-genome sequencing revealed that the resistant isolate possessed an ERG3 mutation resulting in a G111R amino acid substitution.Sterol profiles indicated a reduction in sterol desaturase activity as a result of this mutation.Replacement of both mutant alleles in the resistant isolate with the susceptible isolate's allele restored wild-type susceptibility to all azoles and echinocandins tested.Disruption of ERG3 in the susceptible and resistant isolates resulted in a loss of sterol desaturase activity, high-level azole resistance, and an echinocandin-intermediate to -resistant phenotype.While disruption of ERG3 in C. albicans resulted in azole resistance, echinocandin MICs, while elevated, remained within the susceptible range.This work demonstrates that the G111R substitution in Erg3 is wholly responsible for the altered azole and echinocandin susceptibilities observed in this C. parapsilosis isolate and is the first report of an ERG3 mutation influencing susceptibility to the echinocandins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351
Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323
Breakthrough invasive candidiasis in patients on micafungin.
Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196
Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Rolley, N., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00348-10 · Cited by 168
Kabbara, N., Lacroix, C., Peffault de Latour, R., Socie, G., Ghannoum, M., & Ribaud, P. (2008) · Haematologica · doi:10.3324/haematol.11149 · Cited by 61
Cited by
Antibiotic resistance in probiotic bacteria
Gueimonde, M., Sánchez, B., G. de los Reyes-Gavilán, C., & Margolles, A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00202 · Cited by 691
Mechanism of Action of Bacitracin: Complexation with Metal Ion and C 55 -Isoprenyl Pyrophosphate
Stone, K. J., & Strominger, J. L. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.12.3223 · Cited by 377
The factors affecting effectiveness of treatment in phages therapy
Ly-Chatain, M. H. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00051 · Cited by 331
Multidrug resistant commensal Escherichia coli in animals and its impact for public health
Szmolka, A., & Nagy, B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00258 · Cited by 314
Food and human gut as reservoirs of transferable antibiotic resistance encoding genes
Rolain, J.-M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00173 · Cited by 257
Jones, B. E., Ying, J., Stevens, V., Haroldsen, C., He, T., Nevers, M., Christensen, M. A., Nelson, R. E., Stoddard, G. J., Sauer, B. C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.7495 · Cited by 122
Mortensen, B. L., & Skaar, E. P. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00095 · Cited by 99
Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Fenwick, C., Amad, M., Bailey, M. D., Bethell, R., Bös, M., Bonneau, P., Cordingley, M., Coulombe, R., Duan, J., Edwards, P., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02719-13 · Cited by 99
Eldesouky, H. E., Salama, E. A., Lanman, N. A., Hazbun, T. R., & Seleem, M. N. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-20 · Cited by 56
Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection
Shields, R. K., Nguyen, M. H., Press, E. G., Cumbie, R., Driscoll, E., Pasculle, A. W., & Clancy, C. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01973-15 · Cited by 55
Multiresistant Fusarium Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline?
Al-Hatmi, A., de Hoog, G. S., & Meis, J. F. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s180912 · Cited by 47
Pfaller, M. A., Diekema, D. J., Jones, R. N., & Castanheira, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00782-14 · Cited by 51
Costa, C., Henriques, A., Pires, C., Nunes, J., Ohno, M., Chibana, H., Sá-Correia, I., & Teixeira, M. C. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00170 · Cited by 45
Andrés, M. T., Acosta-Zaldívar, M., & Fierro, J. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03130-15 · Cited by 41
Luna-Tapia, A., Kerns, M. E., Eberle, K. E., Jursic, B. S., & Palmer, G. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04239-14 · Cited by 28
Ouédraogo, A.-S., Compain, F., Sanou, M., Aberkane, S., Bouzinbi, N., Hide, M., Sangaré, L., Ouédraogo-Traoré, R., Jean-Pierre, H., Vendrell, J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00147-16 · Cited by 23
Peters, B. M., Luna-Tapia, A., Tournu, H., Rybak, J. M., Rogers, P. D., & Palmer, G. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00084-17 · Cited by 12
Candida auris metabolism and growth preferences in physiologically relevant skin-like conditions
Nicklas, J. P., Deming, C., Lee-Lin, S., Conlan, S., Shen, Z., Blaustein, R. A., & Segre, J. A. (2026) · mBio · doi:10.1128/mbio.03117-25 · Cited by 8
Lin, W., Peng, Y., Xiang, B., Fang, J., Ye, J., & Guo, P. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04275-y · Cited by 3
Metadata
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-11-20
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- DOI
- 10.1128/aac
- OpenAlex
- W4229657713
- Cited by
- 485
- References
- 7
- Type
- paratext
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.